MetaCap

GSK plc ADR (GSK)

NYSE: GSKHealthcareDrug Manufacturers - GeneralUSD

47.02+0.42 (+0.90%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

After hours: 47.00 -0.04%

GSK stock chart

Technical analysis

Key statistics

All statistics
Market cap
$94.21B
P/E (TTM)
14.83
Forward P/E
9.52
EPS (TTM)
$3.17
Dividend yield
1.45% ($0.68)
Ex-dividend date
Aug 14, 2026
52-week range
42.85 – 61.70
Day range
46.69 – 47.41
Volume / Avg
5.85M / 3.73M
Beta
—
Shares outstanding
2.00B
Next earnings
Oct 28, 2026

52-week range

$42.85$61.70

GSK stock today

Shares of GSK (GSK) finished higher on Oct 7 at $47.02, a gain of 0.90% or $0.42 per share, versus the S&P 500's 0.22% decline. Shares are 23.8% below their 52-week high of $61.70, set on Feb 18, 2026 and 9.7% above the 52-week low of $42.85, in the middle of the past year's range. GSK is down 3.9% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 8.3%.

At 14.8x trailing earnings, GSK trades below the peer-group median of 17.7x. Its forward P/E of 9.5x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. The company is scheduled to report Sep/2026 results on Oct 28 before the market opens; analysts expect EPS of $1.44. GSK pays an annual dividend of $0.68 per share, a 1.45% yield at the current price.

Summary generated from market data by MetaCap's automated system. Methodology

About GSK

Company profile

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer.

Sector
Healthcare
Industry
Drug Manufacturers - General
Headquarters
London
Employees
66,841
IPO year
2022
Website
gsk.com

Analyst forecast

Forecast

Consensus (8 analysts)

hold

Avg. price target

$59.33+26.18%

  • Strong buy 1
  • Buy 2
  • Hold 4
  • Sell 1
  • Strong sell 0

Target range

Low $49.00High $70.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Next report
Oct 28, 2026
EPS estimate
$1.44

Dividends

Dividend history
Annual dividend
$0.68
Dividend yield
1.45%
Last payment
$0.452
Ex-dividend date
Aug 14, 2026

GSK news

All GSK news

GSK peers

Healthcare sector
GSK peer companies
CompanyPrice% ChgMarket capCompare
SNYSanofi ADS40.20+1.62%$96.32Bvs GSK
BMYBristol-Myers Squibb Company59.70+0.18%$121.95Bvs GSK
BIIBBiogen Inc.222.15-0.33%$32.82Bvs GSK
PFEPfizer Inc.28.00+1.82%$159.59Bvs GSK
NVONovo Nordisk A/S38.26+1.95%$168.89Bvs GSK
GILDGilead Sciences Inc.146.85+1.82%$182.09Bvs GSK
GRFSGrifols S.A. ADR7.50-0.27%$5.10Bvs GSK
OGNOrganon & Co.13.79+0.36%$3.62Bvs GSK

Indexes, lists and sector

Appears in lists

GSK stock FAQ

What is GSK's stock price today?

GSK last traded at $47.02 as of Oct 7, 4:00 PM EDT, up 0.90% on the day. Prices are delayed at least 15 minutes.

Does GSK pay a dividend?

Yes. GSK pays $0.68 per share annually, a 1.45% yield. The most recent dividend of $0.452 had an ex-dividend date of Aug 14, 2026.

When is GSK's next earnings date?

GSK is expected to report earnings on Wednesday, October 28, 2026. Analysts expect EPS of $1.44.

What is GSK's P/E ratio?

GSK trades at a trailing P/E ratio of 14.83 and a forward P/E of 9.52, compared with a median of 17.7 for its closest peers.

Has GSK ever split its stock?

Yes. The most recent GSK stock split was a 1226-for-1000 split on Jul 22, 2022, one of 5 splits on record.

What is the GSK 52-week high?

The 52-week high for GSK is $61.70 and the 52-week low is $42.85. The stock is currently 23.8% below its high.

Compare GSK